MALAT1 and pancreatic neoplasm: bPNAs, on the other hand, show a slightly better displacement capability, with EC50 values ranging between 0.2 and 9 μM, albeit with a comparable reduction in the MALAT1 expression levels of bPNA-treated pancreatic cancer cells [47].